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Abstract objective To assess the effectiveness of blood transfusions in a hospital of north-eastern Democratic
Republic of the Congo.
methods Prospective study of children admitted for severe anaemia. During admission, data were
collected on clinical condition and haemoglobin levels, before and after blood transfusion. A linear
regression model was built to explore factors associated with haemoglobin level after transfusion. Risk
factors for mortality were explored through multivariate logistic regression.
results Haemoglobin level (Hb) was below 4 g⁄dl in 35% (230⁄657), between 4 and 6 g⁄dl in 58%
(348⁄657) and at least 6 g⁄dl in another 6% (43⁄657) of the transfused children. A transfusion of
15 ml⁄kg of whole blood increased the Hb from 4.4 to 7.8 g⁄dl. Haemoglobin level after transfusion
was associated with baseline Hb, quantity of delivered blood and history of previous transfusions.
Overall case-fatality rate was 5.6% (37⁄657). Risk factors for deaths were co-morbidities such as chest
infection, meningitis or malnutrition, Hb ‡ 6g⁄dl, impaired consciousness or jugular venous distention
on admission, and provenance.
conclusion Transfusion was a frequent practice, the use of which could clearly have been rationa-
lised. While indications should be restricted, quantities of transfused blood should be adapted to needs.
keywords blood transfusion, Democratic Republic of the Congo, paediatric, risk factors, mortality
Introduction
Severe anaemia is an important cause of morbidity and
mortality in under-ﬁve children in Sub-Saharan Africa
(Phiri et al. 2008). Severe anaemia has mainly been studied
as a complication of severe malaria (Akech et al. 2008b),
but other underlying factors are known to play a role, such
as bacteremia, helminthic infections, HIV, G6PD deﬁ-
ciency, vitamin A and B12 deﬁciencies (Calis et al. 2008).
While trends of severe anaemia over time show a decrease
corresponding to the decrease in malaria incidence
observed in many African settings (Pedro et al. 2010),
similar decreasing trends are not observed in terms of case-
fatality rates of children admitted with severe anaemia,
which remain around 5–10% (Phiri et al. 2008; Pedro
et al. 2010).
According to recommendations by the World Health
Organization (WHO 2002), blood transfusion in children
should be restricted to those with a haemoglobin (Hb) level
below 4 g⁄dl, or between four and 6 g⁄dl with clinical
features of acidosis such as dyspnoea or impaired
consciousness, or hyperparasitaemia above 20%. This
conservative approach to transfusion is based on the
hazards related to this practice in developing countries,
such as viral infection by human immunodeﬁciency virus
(HIV), hepatitis B (HBV) or C (HCV) virus (Marcucci et al.
2004; Madjdpour & Spahn 2005), or bacterial contami-
nation of the blood (Hassall et al. 2009). Withdrawing
blood transfusion from patients with higher Hb levels has
been shown to be safe in Kenya (Akech et al. 2008).
The quantity of blood to be transfused according to
WHO is 5 ml⁄kg of red blood cells or 10 ml⁄kg of whole
blood, which is said to be sufﬁcient to relieve acute
shortage of oxygen carrying capacity (WHO 2002), with
an expected increase in haemoglobin concentration of
approximately 2–3 g⁄dl, corresponding to 2 ml⁄kg of red
blood cells to increase the haemoglobin by 1 g⁄dl. How-
ever, according to other sources, 3 ml⁄kg of red blood cells
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(Dalmas & Wibaut 2003). A simple way to transfuse red
blood cells only is to leave blood to settle down vertically
before administration, to separate red blood cells from the
plasma.
To evaluatethe effectiveness andpotential dangers of
bloodtransfusions inanAfrican medicalcontext, we
conductedaprospectivestudyofchildrenadmittedforsevere
anaemiain north-eastern Democratic Republic ofCongo.
Method
Setting
Bunia is the capital of the District of Ituri, located in the
Eastern Province, in the north-eastern region of the
Democratic Republic of the Congo (DRC). In 2003, the
Swiss section of Me ´decins Sans Frontie `res (MSF-CH) set up
‘Bon Marche ´ Hospital’, a secondary-level hospital, to treat
victims of the internal conﬂict. Over time, the program
shifted progressively towards general care, with a focus on
paediatric services. At the time of the study, it contained
100 paediatric beds, with an average of 500 children
admitted monthly (MSF 2009). In 2008, 350 transfusions
were given on average each month. Malaria transmission is
perennial, although there is a relative increase between
June and December. According to a study on the causes of
mortality conducted from May to July 2007 in the hospital
paediatric service (Nackers 2007), severe anaemia (deﬁned
in this study as a level of haemoglobin <5 g⁄dl, or a
decompensated anaemia) was the second most common
reason for admission after severe malaria. Severe anaemia
was implicated in 27% of the deaths. Deaths in anaemic
children occurred rather late after admission
(13⁄34 = 38% died more than 48 h after admission).
Many children were transfused repeatedly, which put into
question the efﬁciency of the transfusions.
Design
This prospective hospital-based cohort study included
children from four neighbouring health zones (Bunia,
Rwampara, Nizi and Lita) aged 1 month to 4 years,
presenting with severe anaemia deﬁned as a haemoglobin
level below 4 g⁄dl or higher but associated with signs of
cardio-respiratory distress. Informed written consent was
obtained from the caretaker. The protocol was approved
by the Ethics Committee of the University of Kinshasa,
Democratic Republic of Congo and the Ethics Review
Board of Me ´decins Sans Frontie `res.
During admission, data were collected on clinical con-
dition and haemoglobin levels of the children before and
after blood transfusion, 1 and 3 days after the transfusion
and before discharge. Both donor and recipient blood were
screened for hepatitis B surface antigen, anti-hepatitis C
antibodies and syphilis by rapid treponemal test. Donor
blood was systematically screened for HIV, and HIV
screening was proposed to all transfusion recipients (opt-
out approach). Haematocrit and reticulocyte count were
measured. Thin blood smear was examined for hypochro-
mia, micro or macrocytosis, and for parasite count in case
of positive rapid test for malaria. The Emmel test was used
to screen for sickle cell trait. Children were advised to
come for follow-up visits at 1, 2 and 3 months after the
transfusion. During follow-up visits, haemoglobin levels
were checked and clinical condition assessed. In the event
of missed appointments, a tracing visit to the community
was organised. This study focuses on results of the
hospitalisation phase.
Deﬁnitions
Transfusion was indicated in case of severe anaemia,
deﬁned as haemoglobin (Hb) below 4 g⁄dl, or in case of a
moderate anaemia (Hb 4–6 g⁄dl) associated with signs of
cardio-respiratory distress. It could be exceptionally justi-
ﬁed above 6 g⁄dl in case of severe cardio-respiratory
distress. Respiratory distress was deﬁned by tachypnea and
at least one of the following: dyspnoea with signs of
distress (nasal ﬂaring, chest indrawing and grunting),
anxious restlessness or alteration in consciousness due to
hypoxia or hypercapnia. Cardiocirculatory failure was
deﬁned as tachycardia (or bradycardia) and at least one of
the following: a capillary reﬁll time (CRT) ‡3 seconds with
cold extremities or temperature gradient, weak pulse,
jugular venous distention, oliguria, peripheral oedema or
painful hepatomegaly.
Transfusion
According to the hospital guideline, children who needed a
blood transfusion were transfused with 15 ml⁄kg of
packed red blood cells, at a ﬂow of 5 ml⁄kg⁄h (in case of
major distress, blood was given rapidly over the ﬁrst
30 min). Blood was either taken from voluntary donors or
from a family donor if no other donor was available. Blood
was collected with a penta-bag system, which allows direct
preparation of four 100- to 125-ml bags from a 450-ml
bag. Blood was stored vertically to allow for sedimentation
of red blood cells and separation from the plasma. Blood
cross matching was performed in the laboratory. To avoid
gross errors, ABO-compatibility between patient and
transfusion blood was repeated at bedside using the
Bio_Rad card . The transfusion was stopped after
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Furosemide was only recommended in case of clinical signs
of ﬂuid overload.
Data collection and analysis
Data were collected on standardised case report forms,
entered in EpiData (EpiData Association, Odense Den-
mark) and analysed with Stata 11 statistical software
(Statacorp, College Station, TX, USA). In univariate
analysis, categorical variables were compared using chi-
square test, and continuous variables with t-test if nor-
mality could be assumed, else the rank test was used.
Paired t-test was used if comparing observation from the
same subject (for example before and after transfusion).
Factors associated in the univariate analysis at a P-value
below 0.10 were further explored in multivariate models.
To explore factors associated with haemoglobin level after
transfusion, a model was built using a linear regression
model. Post-estimated standardised residuals were analy-
sed to check the good ﬁt of the model, leading to the
exclusion of four observations from the ﬁnal model
(patients with very low initial haemoglobin (£4.3 g⁄dl) and
high haemoglobin after transfusion (‡12.1 g⁄dl), probably
indicating a mistake for one of the two values). Risk factors
for in-hospital mortality were explored through multivar-
iate logistic regression. Goodness-of-ﬁt was assessed by
Hosmer–Lemeshow test. Lost-to-follow-up (LFU) during
hospitalisation was counted as negative outcomes in the
mortality analysis, but not included in raw case-fatality
rates reported. Sensitivity analysis was carried out counting
LFU either as alive or as negative outcome.
Results
Patient characteristics
In total, 657 children were included in the study between
December 2009 and April 2010 (Table 1). The sex ratio
(boy⁄girl) was 1.09. More than 80% of the children
(539⁄657) were below the age of three and 34% (224⁄657)
were below one. 22% (142⁄657) had received a blood
transfusion in the past. Of these, most had been transfused
once previously (82/142 = 57.7%). Median time since
last transfusion was 4 months (interquartile range (IQR):
3–6 months).
On admission, haemoglobin level (Hb) was below 4 g⁄dl
in 35% (230⁄657), between four and 6 g⁄dl in 58%
(348⁄657) and at least 6 g⁄dl in another 6% (43⁄657) of
the children. More than 90% (606⁄657) had an increased
respiratory rate (tachypnoea) and 87.4% (574⁄657) ﬁtted
the deﬁnition of respiratory distress. Most frequently
reported signs of respiratory distress were nostril ﬂare
(534⁄657 = 81.3%) and anxious restlessness
(393⁄657 = 59.8%), while only 14.9% (98⁄657) showed
chest indrawing. Impaired consciousness was reported for
20.2% (133⁄657). Increased heart rate was observed in
73.2% (481⁄657), and a weak pulse was described in
75.2% of the children (494⁄657). Other signs of cardiac
failure were more rarely described. Agreement between
clinicians and protocol deﬁnitions was poor (kappa 0.33
for respiratory distress, j = 0.15 for cardiocirculatory
failure). Clinicians tended particularly to overestimate
cardiocirculatory failure, while they estimated more accu-
rately the proportion of children with respiratory distress.
Co-morbidities
Malaria rapid test (CareStart) was positive in 86% of the
cases. The proportion of parasitised red blood cells was
above 5% in 53% (347⁄657) of the children. The most
frequently diagnosed co-morbidities were respiratory
infections (11%, 73⁄657), septicaemia (3%, 22⁄657) and
meningitis (3%, 18⁄657). Overall, 40.6% of the children
(267⁄657) had another ﬁnal diagnosis that could at least
partly explain the anaemia (malnutrition, HIV infection,
tuberculosis, sickle cell disease, parasitic infection, diges-
tive bleeding, intoxication with local products, pneumonia,
meningitis, septicaemia or another bacterial infection).
Even among the children with a positive rapid test for
malaria, 36.8% (208⁄565) also had another diagnosis.
Most co-morbidities were not identiﬁed during the initial
assessment (for example, only 20 of the 73 patients with a
ﬁnal diagnosis of chest infection had the diagnosis made
initially). Nutritional assessment based on weight for
height was often incomplete (missing height for
207⁄657 = 31.5%). The Crofton score – for tuberculosis
screening – was not performed systematically and its
performance could not be evaluated. No chest radiography
was done.
Transfusion practices
Median delay from admission to transfusion was 4 h
(interquartile range, 2–10 h 30 min). 97 patients (14.8%)
were transfused more than 24 h after admission. All
subjects included were transfused. Red blood cell concen-
trate was left to sediment in 97% (638⁄657) of the cases
before being administered. Bedside blood grouping was not
performed for more than half of the patients
(363⁄657 = 55.5%). Furosemide was almost systemati-
cally administered (630⁄657 = 96.3%), without it being a
formal recommendation. The quantity of blood delivered
by the laboratory was below the quantity recommended to
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ª 2012 Blackwell Publishing Ltd 1459Table 1 Demographic and clinical characteristics of 657 children transfused for severe anaemia, Bon Marche ´ Hospital, DRC, 2009–2010
Total N = 657
Deaths or lost
to follow-up
N = 41 Alive N = 616 Crude OR
n Column % n Row % n Row % [95% CI]
Sex
Male 342 (52.0) 20 (5.8) 322 (94.1) 1
Female 315 (47.9) 21 (6.7) 294 (93.3) 1.15 [0.6; 2.2]
Age
1–11 months 224 (34.1) 25 (11.2) 199 (88.8) 5.2 [1.5; 17.8]
12–23 months 188 (28.6) 10 (5.3) 178 (94.7) 2.3 [0.6; 8.7]
24–35 months 127 (19.3) 3 (2.4) 124 (97.6) 1.2 [0.2; 7.2]
36–47 months 73 (11.1) 2 (2.7) 71 (97.3) 1
48–59 months 41 (6.2) 0 (0.0) 41 (100.0) NA
60 months and above 4 (0.6) 1 (25.0) 3 (75.0) 13.8 [1.0; 188.1]
Provenance (health zone)
Bunia 261 39.7 23 (8.8) 238 (91.2) 1
Rwampara 231 35.2 7 (3.0) 224 (97.0) 0.3 [0.1; 0.8]
Nizi 89 13.5 2 (2.2) 87 (97.7) 0.2 [0.0; 1.0]
Lita 76 11.6 9 (11.8) 67 (88.2) 1.4 [0.6; 3.1]
History of previous transfusion 142 (21.6) 5 (3.5) 137 (96.5) 0.5 [0.2; 1.3]
Haemoglobin (mean; standard
deviation)
4.4 1.1
£4g⁄dl 230 (35.0) 18 (7.8) 212 (92.2) 1.8 [0.9; 3.6]
>4 and £6g⁄dl 384 (58.4) 17 (4.4) 367 (95.6) 1
>6 g⁄dl 43 (6.5) 6 (13.9) 37 (86.0) 3.5 [1.3; 9.5]
Signs of respiratory distress
Tachypnea* 606 (92.2) 37 (6.1) 569 (93.9) 1.3 [0.4; 3.8]
Nasal ﬂaring 534 (81.3) 31 (5.8) 503 (94.2) 0.6 [0.3; 1.4]
Chest indrawing 98 (14.9) 10 (10.2) 88 (89.8) 1.8 [1.1; 2.8]
Anxious restlessness 393 (59.8) 28 (7.1) 365 (92.9) 1.5 [0.7; 2.9]
Impaired consciousness 133 (20.2) 15 (11.3) 118 (88.7) 2.4 [1.2; 4.7]
Tachypnea and at least 1 sign 565 (86.0) 37 (6.5) 528 (93.4) 1.5 [0.5; 4.4]
Respiratory distress according
to clinician
552 (84.0) 37 (6.7) 515 (93.3) 4.5 [0.6; 33.8]
Signs of cardiocirculatory failure
Tachycardia 481 (73.2) 31 (6.4) 450 (93.6) 0.9 [0.4; 1.8]
Weak pulse 494 (75.2) 22 (4.4) 472 (95.5) 0.3 [0.2; 0.6]
Capillary reﬁll time ‡3s  219 (33.3) 13 (5.9) 206 (94.1) 0.9 [0.3; 3.0]
Peripheral oedema 79 (12.0) 2 (2.5) 77 (97.5) 0.4 [0.1; 1.5]
Painful hepatomegaly 127 (19.3) 6 (4.7) 121 (95.3) 0.7 [0.3; 1.7]
Jugular venous distention 181 (27.5) 16 (8.8) 165 (91.2) 1.7 [0.9; 3.3]
Oliguria 28 (4.3) 1 (3.6) 27 (96.4) 0.5 [0.1; 4.1]
Tachycardia and at least 1 sign 423 (64.4) 28 (6.6) 395 (93.4) 1.2 [0.6; 2.4]
Cardiocirculatory failure
according to clinician
552 (84.0) 36 (6.5) 516 (93.5) 1.8 [0.5; 6.1]
CareStart malaria test positive 565 (86.0) 31 (5.5) 534 (94.5) 1
CareStart malaria test negative 80 (12.2) 9 (11.2) 71 (88.7) 2.2 [1.0; 4.8]
Parasitaemia
<0.1% (negative) 86 (13.1) 9 (10.5) 77 (89.5) 1
0.1–1.9% 149 (22.7) 11 (7.4) 138 (92.6) 0.7 [0.3; 1.7]
2.0–4.9% 59 (9.0) 5 (8.5) 54 (91.5) 0.8 [0.2; 2.5]
5.0–9.9% 116 (17.7) 6 (5.2) 110 (94.8) 0.5 [0.2; 1.4]
10.0% and above 234 (35.6) 9 (3.8) 225 (96.1) 0.3 [0.1; 0.9]
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15 ml⁄kg of packed red blood cells), with 96% of the
children receiving <30 ml⁄kg of whole blood and 24%
receiving <20 ml⁄kg. Children received a mean of
15 ml⁄kg of whole blood (SD, 6 ml⁄kg), corresponding to
7.5 ml⁄kg of packed red blood cells. The haemoglobin
level increased signiﬁcantly from 4.4 before transfusion to
7.8 g⁄dl on day 1 (P < 0.001). Increasing the haemoglobin
value of 1 g⁄dl required 4.4 ml⁄kg of whole blood (or
2.2 ml⁄kg of red blood cells, taking a conservative estimate
of half the quantity of whole blood being constituted by
red blood cells). During transfusion, the occurrence of an
adverse event did not automatically lead to interruption of
the transfusion. Only six transfusions were stopped, for
74 recorded events other than fever. The transfusion was
stopped in two cases of urticarial rash without general
symptoms, two cases of malaise without rash (all recov-
ered), one urticarial rash with malaise and restlessness, in
whom the transfusion was stopped within 1 h. He received
dexamethazone and promethazine without success and
died thereafter. Another child died during the transfusion,
with no apparent signs of adverse reaction.
Evolution during admission
Clinical parameters such as heart rate and respiratory rate
improved after transfusion. However, only 22% of the
children were discharged with a corrected anaemia (deﬁned
as haemoglobin above 9 g⁄dl without signs of cardio-
respiratory distress). Multivariate analysis through linear
regression model showed that haemoglobin level after
transfusion was higher if baseline haemoglobin (coeff, 0.56;
95%CI0.45,0.67)andquantityofdeliveredbloodinml⁄kg
(0.04; 95% CI 0.02, 0.06) were higher (Table 2). However,
patients with a history of previous transfusions had lower
haemoglobin levels after transfusion ()0.37; 95%CI
)0.66, )0.08). Transfusion became more efﬁcient during
the course of the study (coeff, 0.01; 95% CI 0.01, 0.02).
Mortality
The overall case-fatality rate was 5.6% (37⁄657; Table 3),
highest in the group of children with the highest haemo-
globin on admission (13.9% (6⁄43) for a Hb ‡ 6g⁄dl
compared with 4.2% (16⁄384) and 6.5% (15⁄230) for
children with a Hb between 4 g⁄dl and 6 g⁄dl, and below
4g⁄dl, respectively). Most children died more than 24 h
after admission (24⁄37 = 65%). Case-fatality was also
highest in both the youngest and oldest age group
(21⁄224 = 9.4% and 1⁄4 = 25%, respectively).
Lost-to-follow-up cases (n = 4) were included as
negative outcomes in the mortality analysis. Clinical
signs associated with a negative outcome (death or
Table 1 (Continued)
Total N = 657
Deaths or lost
to follow-up
N = 41 Alive N = 616 Crude OR
n Column % n Row % n Row % [95% CI]
Co-morbidities
Clinical malnutrition 31 (4.7) 8 (25.8) 23 (74.2) 6.2 [2.6; 15.3]
Chest infection 73 (11.1) 30 (41.1) 43 (58.9) 36.3 [15.1; 87.7]
Meningitis 20 (3.0) 4 (20.0) 16 (80.0) 4.0 [1.3; 12.8]
Septicaemia 22 (3.3) 1 (4.5) 21 (95.4) 0.7 [0.1; 5.4]
*Tachypnea: respiratory rate (RR) >55 beats per minute (bpm)⁄min if age below 2 months, RR >45 bpm if age 2–11 months,
RR > 35 bpm if at least 1 year old.
Tachycardia: heart rate (HR) > 170 bpm if age below 2 months, HR >150 bpm if aged 2–24 months, HR >125 bpm if aged >24 months.
375 missing values.
Table 2 Multivariate analysis of factors associated with haemo-
globin levels after transfusion, under-ﬁve children transfused for
severe anaemia, Ho ˆpital Bon Marche ´, DRC, 2009–2010. Linear
regression model (N = 627)
Coefﬁcient 95% CI P-value
Haemoglobin level on
admission (in g⁄dl)
0.56 0.45, 0.67 <0.001
History of previous
transfusions
)0.37 )0.66, )0.08 0.012
Quantity of whole
blood delivered
(in ml⁄kg)
0.04 0.02, 0.06 <0.001
Date of admission,
(in days)
0.01 0.01, 0.02 <0.001
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chest indrawing (crude OR, 1.8; 95% CI 1.1, 2.8) and
impaired consciousness (crude OR, 2.4; 95% CI 1.2, 3.9).
All children who died had at least one sign of respiratory
distress. Among signs of cardiac distress, there was a trend
for jugular venous distention to be associated with mor-
tality (crude OR, 1.7; 95% CI 0.9, 3.3), while the
occurrence of a weak pulse seemed to be protective (crude
OR, 0.3; 95% CI 0.1, 0.6).
In the multivariate analysis (Table 4), diagnoses of co-
morbidities such as chest infection (adjusted OR, 39.3;
95% CI 16.1–95.8), meningitis (adjusted OR, 10.5; 95%
CI 2.3–48.9) or malnutrition (adjusted OR, 5.4; 95% CI
1.6–18.4) were associated with negative outcome. Other
independent risk factors were a Hb ‡6g⁄dl on admission,
compared with a haemoglobin between 4 and 6 g⁄dl
(adjusted OR, 5.2; 95% CI 1.4–20.1), presence of impaired
consciousness on admission (adjusted OR, 2.5; 95% CI
1.0–6.0) or jugular venous distention (adjusted OR, 3.0;
95% CI 1.2–7.4), provenance from Bunia or Lita (adjusted
OR, 4.2 (95% CI 1.5, 12.1) and 3.8 (95% CI 1.1, 14.0),
respectively), compared with Rwampara. Age, chest in-
drawing and weak pulse were not associated with mor-
tality after adjusting for the other factors. Levels of
parasitaemia seemed associated with reduced mortality
based on the univariate analysis, but there was no more
association after adjusting for other factors such as
co-morbidities.
Discussion
Our results conﬁrm that severe anaemia is a disease of very
young children (often infants and toddlers up to 3 years
old). We were surprised to record such a high proportion of
children (almost one of four) reporting a previous history
of transfusions. This shows that severe anaemia is a
recurrent problem for some children, as has been shown in
Malawi (Phiri et al. 2008). This should lead to an active
search for co-morbidities or underlying factors in children
with recurrent anaemia. The frequency of repeated trans-
fusions should be taken into account in transfusion
Table 3 Respiratory distress, cardiocirculatory failure and case-fatality rate by haemoglobin level in 657 children transfused for
severe anaemia, Ho ˆpital Bon Marche ´, DRC, 2009–2010
No signs of
distress
Both respiratory
distress and
cardiocirculatory
failure
Cardiocirculatory
failure only
Respiratory
distress only Total
Case-fatality
rate
n (%) n (%) n (%) n (%) N (%) n %
Haemoglobin
£4g⁄dl 16 (7.0) 135 (58.7) 14 (6.1) 65 (28.2) 230 (100.0) 15 (6.5)
>4 and £6g⁄dl 24 (6.2) 232 (60.4) 20 (5.2) 108 (28.1) 384 (100.0) 16 (4.2)
>6 g⁄dl 6 (13.9) 19 (44.2) 3 (7.0) 15 (34.9) 43 (100.0) 6 (13.9)
Total 46 (7.0) 386 (58.7) 37 (5.6) 188 (28.6) 657 (100.0) 37 (5.6)
Respiratory distress was deﬁned by tachypnea (respiratory rate (RR) >55 beats per minute (bpm)⁄min if age below 2 months,
RR > 45 bpm if age 2–11 months, RR > 35 bpm if at least 1 year old) and at least one of the following: dyspnea with signs of distress
(ﬂaring of nostrils, intercostal indrawing, xyphoidian depression), anxious restlessness or alteration in consciousness. Cardiac failure was
deﬁned as tachycardia (heart rate (HR) >170 bpm if age below 2 months, HR >150 bpm if aged 2–24 months, HR >125 bpm if aged
>24 months) and at least one of the following: weak pulse, a capillary reﬁll time (CRT) ‡3 s, peripheral edema, painful hepatomegaly,
jugular turgescence or rare urine.
Table 4 Multivariate model of risk factors for hospital
mortality among under-ﬁve children transfused for severe
anaemia, Ho ˆpital Bon Marche ´, DRC, 2009–2010 (41 deceased
or lost-to-follow-up for a total of 650 patients)
Adjusted OR 95% CI P-value
Haemoglobin level
£4g⁄dl 2.2 0.9; 5.3 0.084
>4 and £6g⁄dl 1
>6 g⁄dl 5.2 1.4; 20.1 0.016
Provenance (health zone)
Rwampara 1
Bunia 4.2 1.5, 12.1 0.007
Nizi 0.9 0.1, 5.6 0.937
Lita 3.8 1.1, 14.0 0.04
Impaired consciousness 2.5 1.0, 6.0 0.047
Jugular veinous distention 3.0 1.2, 7.4 0.016
Chest infection 39.3 16.1; 95.8 <0.001
Meningitis 10.5 2.3, 48.9 0.003
Clinical malnutrition 5.4 1.6, 18.4 0.007
Logistic regression model Goodness-of-ﬁt according to Hosmer-
Lemeshow test with 10 probability groups: chi2 with 8 degrees of
freedom 5.21; P = 0.735.
Tropical Medicine and International Health volume 17 no 12 pp 1457–1464 december 2012
Y. Mueller et al. Effectiveness of blood transfusions
1462 ª 2012 Blackwell Publishing Ltdguidelines, because the risk of alloimmunisation increases
with repeated transfusions. Unfortunately, there are no
simple tests to detect irregular antibodies adapted to
remote settings.
It may seem counterintuitive that patients living in close
proximity to the hospital (Bunia health zone) were at
higher risk of death than those coming from further away
(Rwampara and Nizi health zones). This possibly reﬂects
the fact that severely ill children do not even reach the
hospital when they live further away.
The issue of severe anaemia goes beyond severe malaria
only. Only half of the children in our cohort had high levels
of parasitaemia (above 5%). Neither the presence of
malaria nor levels of parasitaemia played a role in terms of
outcome. However, the study took place in a hospital
where severe malaria was probably well managed. Still, the
presence of a positive malaria test should not prevent the
physicians from considering co-morbidities, whether acute
or chronic, especially when quantitative blood smears are
not done.
In practice, children received half of the recommended
amount of blood. This was probably favoured by the use
of the penta-bag system, to save blood for more recipients.
The quantity of transfused blood had an impact on
haemoglobin level after transfusion but, probably because
the quantities were small overall, we could not show an
effect in terms of mortality or need for retransfusion.
Children with severe anaemia who do need blood transfu-
sion should receive an adequate volume. Transfusion of
insufﬁcient quantities of blood can lead to the need for
repeated transfusions, often from different donors. This
increases the risk both of infection and alloimmunisation.
Current WHO recommendations of transfusing 5 ml⁄kg of
red blood cells do not seem adequate, as this would only
increase the haemoglobin value by <2.5 g⁄dl according to
our results.
While leaving blood to sediment is an easy way to
concentrate red blood cells in low-resource settings, it
makes it difﬁcult to estimate precisely the amount of red
blood cells given, as the infusion bags are not graduated.
Also, it is optimistic to assume that half of the volume of
whole blood corresponds to red blood cells, as normal
haematocrit is usually below 50%.
The average haemoglobin level before transfusion
among our population of transfused children can be
considered to be rather high. Many children seem to have
been transfused because of signs of vital distress attributed
to the anaemia without looking for the presence other co-
morbidities or underlying factors. The study was per-
formed where blood was rather easily available compared
with other African contexts, and this seems to have led to
the over-prescription of blood transfusion. However, as
shown by the high case-fatality of children with a high
haemoglobin level, transfusion was not the correct answer
in those children. Decrease in in-hospital mortality of
children with anaemia requires better management of co-
morbidities, based on an in-depth analysis of clinical signs
and physiopathological reasoning.
As all signs of respiratory distress were relatively
frequent, it was difﬁcult to identify which ones were most
associated with mortality. Impaired consciousness was
reported frequently and interpreted as a sign of respiratory
failure, although in most cases, this may point to an
additional diagnosis such as cerebral malaria or meningitis
and is not a marker of the severity of the anaemia. Weak
pulse is a subjective criterion that may easily be overesti-
mated, explaining some of our unexpected results. Clini-
cians had difﬁculty strictly applying deﬁnitions of cardiac
and⁄or respiratory distress. In the context of severe
anaemia, these deﬁnitions should be standardised and
simpliﬁed, in order for physicians to correctly identify
children in need of blood. For example, use of the capillary
reﬁll time, which has been shown to be a prognostic factor
in severe malaria (Evans et al. 2006), should be actively
promoted. Also, distinction between anaemia and pneu-
monia as the cause of the respiratory distress can be
difﬁcult in the initial assessment. This ultimately leads to
many transfusions being given to children with non-severe
anaemia.
Our study questions not only issues concerning transfu-
sions, but most of all, the overall level of care for paediatric
emergencies. While emergency paediatric care represents a
major part of the activity of most hospitals in developing
countries, speciﬁc training of physicians and nursing staff
on emergency paediatric care has been neglected. The
implementation of simple triage measures and training in
better recognition and case management of paediatrics
emergencies including severe anaemia and shock can make
a signiﬁcant difference in terms of patient outcomes
(Molyneux et al. 2006). Recently, MSF has started such
trainings, with very good results and encouraging feed-
backs both from expatriate and national staff.
Although blood transfusion is a frequent procedure,
rules of good transfusion practice such as bedside grouping
should not be overlooked, even in very busy wards. More
attention should be given to recognition and management
of adverse reactions. It is particularly in such contexts,
when there is not much time to think, that precautionary
rules prevent accidents.
Conclusion
In Bunia Hospital, blood transfusions were frequent, the
use of which could clearly be rationalised. Cases of severe
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only one contributing factor to anaemia, while other
co-morbidities and or underlying conditions played an
important part in terms of mortality. Such cases call for
global and integrated management. While indications
should be restricted, quantities of transfused blood should
be adapted to needs, to ensure efﬁciency and lower the
risks associated with blood transfusions from multiple
donors.
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